Loss of SR-BI Down-Regulates MITF and Suppresses Extracellular Vesicle Release in Human Melanoma
Authors:
- Katharina KinslechnerKKKatharina Kinslechner
- Birgit SchützBSBirgit Schütz
- Martina PistekMPMartina Pistek
- Philipp RapolterPRPhilipp Rapolter
- Hans P. WeitzenböckHWHans P. Weitzenböck
- Harald HundsbergerHHHarald Hundsberger
- Wolfgang MikulitsWMWolfgang Mikulits
- Johannes GrillariJGJohannes Grillari
- Clemens RöhrlCRClemens Röhrl
- Markus HengstschlägerMHMarkus Hengstschläger
- Herbert StanglHSHerbert Stangl
- Mario MikulaMMMario Mikula
Open Access
- 1 March 2019
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 20 (5) , 1063
Abstract
Melanoma is a skin tumor with a high tendency for metastasis and thus is one of the deadliest cancers worldwide. Here, we investigated the expression of the scavenger receptor class B type 1 (SR-BI), a high-density lipoprotein (HDL) receptor, and tested for its role in melanoma pigmentation as well as extracellular vesicle release. We first analyzed the expression of SR-BI in patient samples and found a strong correlation with MITF expression as well as with the melanin synthesis pathway. Hence, we asked whether SR-BI could also play a role for the secretory pathway in metastatic melanoma cells. Interestingly, gain- and loss-of-function of SR-BI revealed regulation of the proto-oncogene MET. In line, SR-BI knockdown reduced expression of the small GTPase RABB22A, the ESCRT-II protein VPS25, and SNAP25, a member of the SNARE complex. Accordingly, reduced overall extracellular vesicle generation was detected upon loss of SR-BI. In summary, SR-BI expression in human melanoma enhances the formation and transport of extracellular vesicles, thereby contributing to the metastatic phenotype. Therapeutic targeting of SR-BI would not only interfere with cholesterol uptake, but also with the secretory pathway, therefore suppressing a key hallmark of the metastatic program.Keywords
Funding Information
- Austrian Science Fund (P 25336-B13)
- NÖ Forschungs- und Bildungsges.m.b.H. (LS14-007)
This publication has 44 references indexed in Scilit:
- HDL endocytosis and resecretionBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2013
- Scavenger receptor class B type I regulates cellular cholesterol metabolism and cell signaling associated with breast cancer developmentBreast Cancer Research, 2013
- Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through METNature Medicine, 2012
- Characterization of endocytic compartments after holo-high density lipoprotein particle uptake in HepG2 cellsHistochemistry and Cell Biology, 2009
- Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survivalProceedings of the National Academy of Sciences, 2009
- Structure and Function of the ESCRT-II-III Interface in Multivesicular Body BiogenesisDevelopmental Cell, 2009
- Brn-2 Represses Microphthalmia-Associated Transcription Factor Expression and Marks a Distinct Subpopulation of Microphthalmia-Associated Transcription Factor–Negative Melanoma CellsCancer Research, 2008
- Identification of Neural Crest and Glial Enhancers at the Mouse Sox10 Locus through Transgenesis in ZebrafishPLOS Genetics, 2008
- The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasisBMC Medical Genomics, 2008
- Mitf regulation of Dia1 controls melanoma proliferation and invasivenessGenes & Development, 2006